News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-09-28 3:23:2 am Citius Pharmaceuticals: Not A Lot Of Cash Left Ahead Of LYMPHIR BLA Resubmission SeekingAlpha
2023-09-21 6:35:0 am Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference GlobeNewswire
2023-09-18 1:30:0 pm Citius Pharmaceuticals Reschedules Participation in Sidoti Small-Cap Virtual Investor Conference for November 2023 PR Newswire
2023-09-13 1:30:0 pm Citius Pharmaceuticals Mourns the Loss of Board Member, Howard Safir PR Newswire
2023-09-08 5:0:0 am Citius Pharmaceuticals, Inc. Receives Regulatory Guidance from the U.S. Food and Drug Administration (FDA) regarding the Planned Resubmission of the BLA for LYMPHIR™ PR Newswire
2023-09-06 1:30:0 pm Citius Pharmaceuticals to Participate in H.C. Wainwright and Sidoti Investor Conferences in September 2023 PR Newswire
2023-09-04 3:46:14 am Breakeven On The Horizon For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Simply Wall St.
2023-08-14 1:15:0 pm Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2023 Financial Results and Provides Business Update PR Newswire
2023-08-10 5:37:0 am Citius Pharmaceuticals Reaches 92 Event Milestone in Mino-Lok® Phase 3 Trial PR Newswire
   

Please consider a small donation if you think this website provides you with relevant information